← Leaderboards
Wentian Yang
Rhode Island Hospital
$4,477,149
Attributed
$4,477,149
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $493.3K · FY2009–25$500K$375K$250K$125K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,477,149 · 9
By mechanism
R01$2,738,832 · 2
R21$1,165,949 · 3
P20$472,369 · 3
R56$99,999 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Ptpn11 Gene”
- Robert M Krug · University Of Texas Austin$10,181,619
- Adolfo Garcia-Sastre · Jackson Laboratory$8,968,321
- Benjamin G. Neel · New York University School Of Medicine$8,566,418
- Kevin M Shannon · University Of California San Francisco$7,992,821
- Bruce D Gelb · Icahn School Of Medicine At Mount Sinai$7,621,307
- Peter Palese · Mount Sinai School Of Medicine Of Nyu$7,440,929
Research focus
Ptpn11 GeneMolecularCellsProtein Tyrosine PhosphataseSignal TransductionHomeostasisSkeletalBoneNovel TherapeuticsMutationPhenotypeBiologyStem CellsTranscription FactorIn VitroPlayProgenitorPromoterProtein Tyrosine KinaseGenetic TranscriptionPost-Translational Protein ProcessingGrowthIn VivoMesenchymal Stem Cells
Grant awards (16)
SHP2's Regulation of the Bone Marrow Stroma and Hematopoietic Crosstalk$493,310
R01 · FY2025 · DK · contact PI
SHP2's Regulation of the Bone Marrow Stroma and Hematopoietic Crosstalk$493,310
R01 · FY2024 · DK · contact PI
Application of SHP2 PROTAC to Mitigate Articular Cartilage Degeneration$180,400
R21 · FY2023 · AR · contact PI
Application of SHP2 PROTAC to Mitigate Articular Cartilage Degeneration$213,664
R21 · FY2022 · AR · contact PI
SHP2 Regulation of the Plasticity of Bone Marrow Osterix+ Stroma$99,999
R56 · FY2022 · DK · contact PI
Role of GI OSTERIX in Gut and Bone Biology$394,064
R21 · FY2021 · AR · contact PI
Role of PTPN11 in Cartilage Stem Cells and Tumorigenesis$354,200
R01 · FY2019 · AR · contact PI
Role of PTPN11 in Cartilage Stem Cells and Tumorigenesis$354,200
R01 · FY2018 · AR · contact PI
Role of PTPN11 in Cartilage Stem Cells and Tumorigenesis$354,200
R01 · FY2017 · AR · contact PI
Role of PTPN11 in Cartilage Stem Cells and Tumorigenesis$343,464
R01 · FY2016 · AR · contact PI
Role of PTPN11 in Cartilage Stem Cells and Tumorigenesis$346,148
R01 · FY2015 · AR · contact PI
TYORISINE PHOSPHATASE SHP2 IN HEMATOPOIETIC STEM CELL PROPERTY MAINTENANCE$210,372
P20 · FY2011 · RR · contact PI
TYORISINE PHOSPHATASE SHP2 IN HEMATOPOIETIC STEM CELL PROPERTY MAINTENANCE$211,128
P20 · FY2010 · RR · contact PI
Shp2 in Osteoclastogenesis and Bone Remodeling$172,074
R21 · FY2010 · AR · contact PI
Shp2 in Osteoclastogenesis and Bone Remodeling$205,747
R21 · FY2009 · AR · contact PI
PILOT 1: PROTEIN TYROSINE PHOSPHATASE SHP2 IN OSTEOCLASTOGENESIS/BONE REMODEL$50,869
P20 · FY2009 · RR · contact PI